van der Heijden L, van de Sande M A J, van der Geest I C M, Schreuder H W B, van Royen B J, Jutte P C, Bramer J A M, Öner F C, van Noort-Suijdendorp A P, Kroon H M, Dijkstra P D S
Department of Orthopedic Surgery, Leiden University Medical Center (LUMC), Postzone J11-70, PO Box 9600, 2300 RC, Leiden, The Netherlands,
Eur Spine J. 2014 Sep;23(9):1949-62. doi: 10.1007/s00586-014-3263-5. Epub 2014 Mar 11.
Evaluation of recurrences, complications and function at mid-term follow-up after curettage for sacral giant cell tumor (GCT).
We retrospectively studied all 26 patients treated for sacral GCT in the Netherlands (from 1990 to 2010). Median follow-up was 98 (6-229) months. All patients underwent intralesional excision, 21 with local adjuvants, 5 radiotherapy, 3 IFN-α, 1 bisphosphonates. Functional outcome was assessed using Musculoskeletal Tumor Society (MSTS) score. Statistics were performed with Kaplan-Meier, Cox regression, log rank and Mann-Whitney U.
Recurrence rate was 14/26 after median 13 (3-139) months and was highest after isolated curettage (4/5). Soft tissue masses >10 cm increased recurrence risk (HR = 3.3, 95 % CI = 0.81-13, p = 0.09). Complications were reported in 12/26 patients. MSTS was superior in patients without complications (27 vs. 21; p = 0.024).
Recurrence rate for sacral GCT was highest after isolated curettage, indicating that (local) adjuvant treatment is desired to obtain immediate local control. Complications were common and impaired function.
评估骶骨巨细胞瘤刮除术后中期随访时的复发情况、并发症及功能。
我们回顾性研究了荷兰1990年至2010年间接受治疗的所有26例骶骨巨细胞瘤患者。中位随访时间为98(6 - 229)个月。所有患者均接受病灶内切除,21例使用局部辅助治疗,5例接受放疗,3例使用α干扰素,1例使用双膦酸盐。使用肌肉骨骼肿瘤学会(MSTS)评分评估功能结果。采用Kaplan - Meier法、Cox回归、对数秩检验和Mann - Whitney U检验进行统计学分析。
中位13(3 - 139)个月后复发率为14/26,单纯刮除术后复发率最高(4/5)。软组织肿块>10 cm会增加复发风险(HR = 3.3,95% CI = 0.81 - 13,p = 0.09)。26例患者中有12例报告了并发症。无并发症患者的MSTS评分更高(27比21;p = 0.024)。
单纯刮除术后骶骨巨细胞瘤的复发率最高,这表明需要(局部)辅助治疗以实现即刻局部控制。并发症常见且影响功能。